Pharma Journalist -

SMi reports: Registration is now open for the Oligonucleotide Therapeutics and Delivery Conference, which will convene in London on 22nd and 23rd September.  Established on the…
Read More...

With only a few weeks left to go, the STING & TLR-Targeting Therapies Summit has announced some exciting updates as the industry prepares for this definitive meeting. Over 100…
Read More...

Arriving at a critical point for field, the Non-Small Cell Lung Cancer Drug Development Summit will enable attendees to see a full picture of the clinical trial landscape and identify…
Read More...

ExCellThera Inc., a clinical-stage cell and molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, and Ossium…
Read More...

PRA Health Sciences announced the expansion of its pharmacovigilance solution to offer full post-marketing services for authorized COVID-19 vaccines and therapeutics, including…
Read More...

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, and OyaGen, Inc. (OyaGen), a pre-clinical biotechnology research company, announced an exclusive…
Read More...

Pfizer Inc. and BioNTech SE announced they will supply an additional 100 million doses of COMIRNATY, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states in…
Read More...

Johnson & Johnson announced that the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has provided updated guidance for use of the Company’s…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,  announced a new supply agreement with Israel for 2022. Under the terms of this…
Read More...

Janux Therapeutics announced the closing of a $125 million Series B financing led by RA Capital Management and joined by new investors BVF Partners L.P., EcoR1 Capital, Hartford…
Read More...